Structure-based design and discovery of potent and selective KDM5 inhibitors

被引：39
|
作者：
Nie, Zhe [1 ]
Shi, Lihong [1 ]
Lai, Chon [1 ]
O'Connell, Shawn M. [1 ,3 ]
Xu, Jiangchun [1 ]
Stansfield, Ryan K. [1 ,4 ]
Hosfield, David J. [2 ]
Veal, James M. [1 ,4 ]
Stafford, Jeffrey A. [1 ,4 ]
机构：
[1] Celgene Corp, 10300 Campus Point Dr,Suite 100, San Diego, CA 92121 USA
[2] Univ Chicago, Ben May Dept Canc Res, 929 East 57th St, Chicago, IL 60637 USA
[3] Pfizer Inc, Groton, CT 06340 USA
[4] Jecure Therapeut, San Diego, CA USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2018年 / 28卷 / 09期
关键词：
Epigenetics; Histone lysine demethylase; KDM5; Tri-methylated H3K4; Structure-based design; HISTONE DEMETHYLASES; CANCER; CELLS; MELANOMA; TARGETS;
D O I：
10.1016/j.bmcl.2018.03.083
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Histone lysine demethylases (KDMs) play a key role in epigenetic regulation and KDM5A and KDM5B have been identified as potential anti-cancer drug targets. Using structural information from known KDM4 and KDM5 inhibitors, a potent series of pyrazolylpyridines was designed. Structure-activity relationship (SAR) exploration resulted in the identification of compound 33, an orally available, potent inhibitor of KDM5A/5B with promising selectivity. Potent cellular inhibition as measured by levels of tri-methylated H3K4 was demonstrated with compound 33 in the breast cancer cell line ZR-75-1. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1490 / 1494
页数：5
相关论文
共 50 条
  • [41] Structure-based design of novel potent nonpeptide thrombin inhibitors
    Hauel, NH
    Nar, H
    Priepke, H
    Ries, U
    Stassen, JM
    Wienen, W
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1757 - 1766
  • [42] Structure-based design and optimization of potent inhibitors of the adenoviral protease
    Grosche, Philipp
    Sirockin, Finton
    Mac Sweeney, Aengus
    Ramage, Paul
    Erbel, Paul
    Melkko, Samu
    Bernardi, Anna
    Hughes, Nicola
    Ellis, David
    Combrink, Keith D.
    Jarousse, Nadine
    Altmann, Eva
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (03) : 438 - 443
  • [43] Discovery of Novel and Potent Cdc25 Phosphatase Inhibitors Based on the Structure-Based De Novo Design
    Park, Hwangseo
    Jung, Suk-Kyeong
    Bahn, Young Jae
    Jeong, Dae Gwin
    Ryu, Seong Eon
    Kim, Seung Jun
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2009, 30 (06) : 1313 - 1316
  • [44] Discovery of novel and potent Cdc25 phosphatase inhibitors based on the structure-based de novo design
    Department of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Korea, Republic of
    不详
    不详
    不详
    Bull. Korean Chem. Soc., 2009, 6 (1313-1316):
  • [45] Discovery of Potent Inhibitors of Soluble Epoxide Hydrolase by Combinatorial Library Design and Structure-Based Virtual Screening
    Xing, Li
    McDonald, Joseph J.
    Kolodziej, Steve A.
    Kurumbail, Ravi G.
    Williams, Jennifer M.
    Warren, Chad J.
    O'Neal, Janet M.
    Skepner, Jill E.
    Roberds, Steven L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (05) : 1211 - 1222
  • [46] Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach
    de Souza, Mariana L.
    Rezende Junior, Celso de Oliveira
    Ferreira, Rafaela S.
    Espinoza Chavez, Rocio Marisol
    Ferreira, Leonardo L. G.
    Slafer, Brian W.
    Magalhaes, Luma G.
    Krogh, Renata
    Oliva, Glaucius
    Cruz, Fabio Cardoso
    Dias, Luiz Carlos
    Andricopulo, Adriano D.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (02) : 1028 - 1041
  • [47] DISCOVERY OF TRIKETONE-QUINOXALINE HYBRIDS AS POTENT HPPD INHIBITORS USING STRUCTURE-BASED DRUG DESIGN
    Baifeng ZHENG
    Yaochao YAN
    Can FU
    Guangyi HUANG
    Long ZHAO
    Qiong CHEN
    Renyu QU
    Guangfu YANG
    FrontiersofAgriculturalScienceandEngineering, 2022, 9 (01) : 133 - 145
  • [48] Structure-based design and discovery of orally-bioavailable potent nonbenzmidine Factor Xa inhibitors.
    Lam, PYS
    Li, RH
    Clark, CG
    Adams, JJ
    Galemmo, RA
    Fevig, JM
    Pinto, DJ
    Quan, ML
    He, MY
    Han, Q
    Alexander, RS
    Rossi, KA
    Wong, PC
    Luettgen, JM
    Aungst, BJ
    Wright, MR
    Bai, SA
    Knabb, RM
    Wexler, RR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U594 - U594
  • [49] Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors
    Teuscher, Kevin B.
    Mills, Jonathan J.
    Tian, Jianhua
    Han, Changho
    Meyers, Kenneth M.
    Sai, Jiqing
    South, Taylor M.
    Crow, Mackenzie M.
    Van Meveren, Mayme
    Sensintaffar, John L.
    Zhao, Bin
    Amporndanai, Kangsa
    Moore, William J.
    Stott, Gordon M.
    Tansey, William P.
    Lee, Taekyu
    Fesik, Stephen W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (24) : 16783 - 16806
  • [50] DISCOVERY OF TRIKETONE-QUINOXALINE HYBRIDS AS POTENT HPPD INHIBITORS USING STRUCTURE-BASED DRUG DESIGN
    Zheng, Baifeng
    Yan, Yaochao
    Fu, Can
    Huang, Guangyi
    Zhao, Long
    Chen, Qiong
    Qu, Renyu
    Yang, Guangfu
    FRONTIERS OF AGRICULTURAL SCIENCE AND ENGINEERING, 2022, 9 (01) : 133 - 145
12345